FDA Grants Full Approval to Amgen's Imdelltra (tarlatamab-dlle) in Extensive Stage Small Cell Lung Cancer

Nov 20, 2025 - 05:00
 0  2
THOUSAND OAKS, Calif., Nov. 19, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0